The iTind procedure is a new minimally invasive treatment that provides rapid and effective relief of enlarged prostate symptoms.1
The treatment gently reshapes the prostate, creating new channels through which urine can flow. The iTind procedure does not cause the side effects often associated with prescription medications, and initial studies have shown that it preserves sexual function, urinary continence and avoids many of the complications that are typically associated with major surgery.1
The iTind procedure is intended for the treatment of symptoms due to urinary outflow obstruction secondary to benign prostatic hyperplasia (BPH) in men age 50 and above.
The prostate is a small gland located right below the neck of the bladder and is part of the male reproductive system. The urethra, which carries urine from the bladder outside the body, runs through the prostate gland.
A healthy prostate gland is approximately the shape and size of a walnut. As men age, the prostate gland often becomes enlarged. This very common process is called Benign Prostatic Hyperplasia (BPH), or enlarged prostate. This causes the prostate to press against the urethra, causing chronic and sometimes troublesome lower urinary tract symptoms that can severely affect your quality of life. These include:
Normal Prostate
Enlarged Prostate
Prostate
A walnut-shaped gland in men that surrounds the urethra at the neck of the bladder and supplies the fluid for semen.
Urethra
The canal that transports urine from the body.
The iTind procedure is a straightforward treatment performed by a urologist either in the hospital or a clinic. The device is placed in the prostatic urethra in a folded configuration. During the 5 to 7-day treatment, it slowly expands and exerts gentle pressure at three precise points to widen the opening through which urine flows through the prostatic urethra and then out of the body. After 5 to 7 days, the device is completely removed. Clinical trials demonstrate that the newly remodeled prostatic urethra will continue to provide long-lasting relief of BPH symptoms.2
Device Implantation
Expanded After 5 Days
Device is Removed
Quality of Life2
Rapid Symptom Relief1,2,3
Straightforward Office Procedure
Preserves Sexual Function and Continence2,3
Durable Results1
Leave Without a Catheter1
Implantation of the iTind device may cause pelvic discomfort, blood in urine, and painful or urgent urination. In rare cases, the iTind device may cause urinary tract infection or a sudden difficulty to urinate.
No cutting or heating prostate Recover in the comfort of your No permanent implant No overnight hospital stay1,2,3 No side effects from prescription In-office procedure2 Majority of men do not require a catheter1
Men over age 40*
Men over age 60*
Of all men will develop BPH in their lifetime*Urology Care Foundation, Benigh Prostatic Hyperplasia. September 2021
Locate a physician in your area offering the iTind procedure.
“It's been 15 months since the iTindTM procedure. The first time I urinated I was amazed. I felt like I was 16 years old again.”
— Jim, iTind procedure patient“Literally within a day of having the iTind device removed, I texted my urologist and said I never knew it could be this good. For me, to be able to have solved that problem within a week, and no longer have to take BPH medications anymore, was just amazing.”
— Dan, iTind procedure patient* Results may vary.
The iTind procedure may not be for everyone. Please consult with a doctor to see if the iTind procedure is right for you. Dan & Jim are actual patients and unpaid speakers.
Take the International Prostate Symptom Score (IPSS) quiz to understand the severity of your symptoms.
The iTind procedure is a 5-7 day treatment for lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH), or enlarged prostate.
The iTind device is placed in the prostate and stays in place for about a week. During this time, the iTind device slowly expands to widen the opening through which urine flows. At the end of the treatment, the iTind device is completely removed. There is no permanent implant or heat treatments. No prostate tissue is removed and initial studies have shown there is no impact on sexual function.1,2
The iTind procedure is a new alternative to prescription medication or invasive surgery. Ask your doctor about the iTind procedure if you do not want to take a pill every day, or if you have tried standard drug treatments and were unsatisfied with the level of symptomatic relief or the way they made you feel. The iTind procedure might also be the right choice for you if you are interested in preserving your sexual function and continence1,2 are worried about having a permanent implant, or are concerned about undergoing a surgery that would involve a long recovery and downtime.
Your doctor will insert the iTind device into the prostatic urethra in the hospital or clinic. Typically, patients return home within a few hours without a catheter.1 After 5 to 7 days at home, you will return to your doctor’s office and the iTind device will be completely removed. There may some slight discomfort during the 5 to 7 days, but most patients feel rapid symptomatic relief and return to their normal activities shortly after removal of iTind.1,2
Most patients experience only mild to moderate discomfort while the iTind device is in place, however patient experience is variable.1,2
The most common side effects experienced are the feeling of pressure in the area of the perineum, an increased frequency and urgency to urinate, light blood in urine, and slight burning upon urination. However, any side effects experienced typically subside shortly after the iTind device is removed.1,2
After insertion of the iTind device, you may be kept for a few hours for observation. Upon returning home you may resume most normal activities depending on your personal level of comfort and your doctor’s advice.
Most patients start to experience symptom relief shortly after the removal.1,2 Symptoms typically continue to improve over the following 6 to 12 weeks.1,2
In clinical studies there have been no indications of long-term adverse side effects.1 Since the iTind device is completely removed at the end of the treatment week, there is no risk of implant migration, encrustation, or tissue overgrowth. Moreover, there are no obstacles in maintaining a regular prostate screening program, including physical exams or any type of imaging, such as MRI, if needed.4
The device positioning helps to ensure that no damage is caused to sperm ducts or sphincters, avoiding risks of sexual dysfunction. In clinical studies, sexual function was preserved among patients treated with the iTind System.1,2
Durability has been demonstrated in clinical studies out to three years in terms of symptom improvement, urinary flow and quality of life in a significant number of patients.1 The iTind procedure does not preclude retreatment or other BPH treatments, should they be needed or desired in the future.
Depending on your lifestyle and anatomy, the iTind System may not be the best treatment for you. Consult with your doctor to determine whether the iTind System is right for you.
You can read more about the clinical data here.
The iTind procedure is approved for use in the European Union, UK, Israel, Australia, Brazil, Canada and the USA.
Locate a physician in your area offering the iTind procedure.
